SHANGHAI, Oct. 20, 2025 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announces that the research results of the Phase Ib registrational clinical trial of satricabtagene autoleucel...
Hence then, the article about carsgen presents preliminary results on satri cel for adjuvant therapy of pancreatic cancer at esmo congress 2025 was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( CARsgen Presents Preliminary Results on Satri-cel for Adjuvant Therapy of Pancreatic Cancer at ESMO Congress 2025 )
Also on site :
- James Denton Returns to Hallmark in Tearjerker Holiday Movie ‘A Season of Promises’ — Get a Sneak Peek
- The midterms didn’t stop the AI buildout. They simply repriced it—and OpenAI is already promising to pay up
- Tom Hanks called this 95% Rotten Tomatoes show ‘one of the greatest things’ he’s ever watched (hint: It’s not ‘Breaking Bad,’ ‘GOT’ or ‘The Sopranos)